跳至主要内容
临床试验/ACTRN12607000255482
ACTRN12607000255482已完成2 期

Efficacy and safety of a Chinese herbal medicine formula in the management of simple obesity: Randomised placebo-controlled clinical trial

Prof. Charlia Xue0 个研究点目标入组 80 人开始时间: 2007年5月11日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • Subjects have BMI greater than 30 kg/m2;•Not involved in other clinical trials for the treatment of obesity; •Agree to avail themselves for the period of the study; and •Provide written consent for participation.

排除标准

  • Subjects with one or more of the following conditions will be excluded from study:•Loosing more than 5kg in the past 3 months;•Endocrine disorders other than type 2 diabetes mellitus; •Uncontrolled hypertension; •Autoimmune or cardiovascular diseases or carrying pace-maker; •Lactating or pregnant women; •Those using drugs affecting the central nervous system or lipid lowering drugs;•Obesity known caused by pharmacotherapy;•Therapy for weight control in the last 6 months;•Kidney or hepatic disease;•Unable to read or understand English.

研究者

发起方
Prof. Charlia Xue

相似试验

已完成
3 期
Efficacy and Safety of the Chinese Herbal Formula Granules in Chronic Kidney Disease Stage 3: A Prospective, Multi-center, Randomized, Placebo-controlled, Double-blind Clinical Trialephrology
ITMCTR1900002601Affiliated Hospital of Nanjing University of Chinese Medicine
招募中
不适用
Effectiveness and safety of a kind of Chinese herbal medicine compound combination in the treatment of portal hypertensive gastropathy in cirrhosis:protocol for a clinical study
ITMCTR2100004509Kailuan General Hospital, Tangshan, Hebei
已完成
3 期
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis media
DRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
进行中(未招募)
不适用
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestations
EUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
已完成
1 期
The Effects of a Chinese Herbal Medicine (VGHBPH0) on Patients with Benign Prostatic Hyperplasia: A Pilot StudyBenign Prostatic Hyperplasia
ITMCTR2000002937Center for Traditional Medicine, Taipei Veterans General Hospital
Efficacy and safety of a Chinese herbal medicine... | 临床试验